Evogene (EVGN) News Today $1.18 0.00 (0.00%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Evogene (NASDAQ:EVGN) Now Covered by StockNews.comApril 27, 2025 | americanbankingnews.comEvogene To Sell Majority Of Lavie Bio To ICL For Undisclosed TermsApril 23, 2025 | nasdaq.comWhy Evogene Ltd. (EVGN) Soared on MondayApril 22, 2025 | msn.comEvogene selling the activity of Lavie Bio subsidiary to ICLApril 21, 2025 | markets.businessinsider.comICL übernimmt Evogene-Tochter Lavie BioApril 21, 2025 | de.investing.comICL to Acquire the Activity of Evogene's Subsidiary, Lavie BioApril 21, 2025 | prnewswire.comEvogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | msn.comEvogene Ltd. (EVGN) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comEvogene Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 6, 2025 | prnewswire.comEvogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025March 6, 2025 | prnewswire.comEvogene Schedules Fourth Quarter 2024 Financial Results ReleaseFebruary 20, 2025 | prnewswire.comAgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat DiseaseFebruary 13, 2025 | prnewswire.comEvogene Ltd. Reschedules Special General Meeting Due to Lack of QuorumFebruary 5, 2025 | tipranks.comEvogene Ltd. (EVGN)January 25, 2025 | ca.finance.yahoo.comEvogene-Aktie erreicht 52-Wochen-Tief bei 1,25 US-DollarDecember 17, 2024 | de.investing.comEvogene-Aktie erreicht 52-Wochen-Tief bei 1,44 US-DollarDecember 5, 2024 | de.investing.comEvogene price target lowered to $5 from $12 at Lake StreetNovember 22, 2024 | markets.businessinsider.comEvogene Ltd. (EVGN) Q3 2024 Earnings Call TranscriptNovember 21, 2024 | seekingalpha.comEvogene Reports Third Quarter 2024 Financial ResultsNovember 21, 2024 | prnewswire.comLake Street Keeps Their Buy Rating on Evogene (EVGN)November 20, 2024 | markets.businessinsider.comEvogene Q3 2024 Earnings PreviewNovember 20, 2024 | msn.comA Glimpse of Evogene's Earnings PotentialNovember 20, 2024 | benzinga.comLavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial ResultsNovember 19, 2024 | prnewswire.comLavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field TrialsNovember 12, 2024 | prnewswire.comEvogene Schedules Third Quarter 2024 Financial Results ReleaseNovember 7, 2024 | prnewswire.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,13 US-DollarNovember 1, 2024 | de.investing.comEvogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule DesignOctober 31, 2024 | prnewswire.comCasterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in KenyaOctober 29, 2024 | prnewswire.comEvogene Ltd. (NASDAQ:EVGN) Short Interest Up 83.6% in OctoberEvogene Ltd. (NASDAQ:EVGN - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 26,800 shares, an increase of 83.6% from the September 30th total of 14,600 shares. Based on an average trading volume of 32,100 shares, the days-to-cover ratio is currently 0.8 days. Currently, 0.5% of the shares of the company are short sold.October 26, 2024 | marketbeat.comEvogene (NASDAQ:EVGN) Stock Price Passes Below 200 Day Moving Average - Here's WhyEvogene (NASDAQ:EVGN) Stock Passes Below 200-Day Moving Average - What's Next?October 25, 2024 | marketbeat.comEvogene (NASDAQ:EVGN) Research Coverage Started at StockNews.comStockNews.com assumed coverage on Evogene in a research report on Friday. They set a "sell" rating on the stock.October 25, 2024 | marketbeat.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,21 US-DollarOctober 17, 2024 | de.investing.comEvogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving Average - Should You Sell?Evogene (NASDAQ:EVGN) Share Price Passes Below 200-Day Moving Average - Should You Sell?October 9, 2024 | marketbeat.comWatershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing TechnologyOctober 8, 2024 | prnewswire.comStockNews.com Begins Coverage on Evogene (NASDAQ:EVGN)StockNews.com initiated coverage on shares of Evogene in a research report on Tuesday. They set a "sell" rating for the company.October 1, 2024 | marketbeat.comLavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-BiologicalsSeptember 30, 2024 | prnewswire.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,6 US-DollarSeptember 25, 2024 | de.investing.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,78September 16, 2024 | de.investing.comEvogene (NASDAQ:EVGN) Share Price Crosses Below 200 Day Moving Average of $6.53Evogene (NASDAQ:EVGN) Share Price Crosses Below Two Hundred Day Moving Average of $6.53September 7, 2024 | marketbeat.comEvogene secures $5.5 million in direct offeringAugust 25, 2024 | investing.comLake Street Capital Cuts Evogene (NASDAQ:EVGN) Price Target to $12.00Lake Street Capital lowered their target price on shares of Evogene from $30.00 to $12.00 and set a "buy" rating for the company in a research note on Friday.August 23, 2024 | marketbeat.comEvogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private PlacementAugust 23, 2024 | prnewswire.comEvogene: EPS übertrifft Schätzungen um 0,19 $ - Umsatz besser als erwartetAugust 23, 2024 | de.investing.comEvogene Ltd. (NASDAQ:EVGN) Q2 2024 Earnings Call TranscriptAugust 23, 2024 | msn.comEVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024August 22, 2024 | investorplace.comEvogene Reports Second Quarter 2024 Financial ResultsAugust 22, 2024 | prnewswire.comEvogene Q2 2024 Earnings PreviewAugust 21, 2024 | msn.comEvogene (EVGN) Scheduled to Post Quarterly Earnings on ThursdayEvogene (NASDAQ:EVGN) will be releasing earnings before the market opens on Thursday, August 22, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=621459)August 15, 2024 | marketbeat.comEvogene Regains Compliance with Nasdaq Minimum Closing Bid Price RuleAugust 12, 2024 | prnewswire.comEvogene Schedules Second Quarter 2024 Financial Results ReleaseAugust 12, 2024 | prnewswire.com Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address EVGN Media Mentions By Week EVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVGN News Sentiment▼0.000.72▲Average Medical News Sentiment EVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVGN Articles This Week▼01▲EVGN Articles Average Week Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TOMZ News Today BSLK News Today GURE News Today NITO News Today SNES News Today DNMR News Today CNEY News Today TANH News Today LNZAW News Today PCTTU News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVGN) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVGN Stock Free EVGN Stock Alerts